Chemical Component Summary

Name5-chloro-N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide
SynonymsGlibenclamide; Glyburide
Identifiers5-chloranyl-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide
FormulaC23 H28 Cl N3 O5 S
Molecular Weight494.004
TypeNON-POLYMER
Isomeric SMILESCOc1ccc(cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3)Cl
InChIInChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)
InChIKeyZNNLBTZKUZBEKO-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count61
Chiral Atom Count0
Bond Count63
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB01016 
NameGlyburide
Groups approved
DescriptionGlyburide is a second generation sulfonylurea used to treat patients with diabetes mellitus type II.[L8123] It is typically given to patients who cannot be managed with the standard first line therapy, [metformin].[L8123] Glyburide stimulates insulin secretion through the closure of ATP-sensitive potassium channels on beta cells, raising intracellular potassium and calcium ion concentrations.[A183617] Glyburide was granted FDA approval on 1 May 1984.[L8117] A formulation with metformin was granted FDA approval on on 31 July 2000.[L8120]
Synonyms
  • Glibenclamide
  • 1-((p-(2-(5-chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea
  • Glibenclamidum
  • 1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea
  • Glyburide
Brand Names
  • Amglidia
  • Glyburide
  • Diabeta Tablets 2.5mg
  • GlyBURIDE
  • Euglucon
IndicationGlyburide is indicated alone or as part of combination product with metformin, as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus.[L8120,L8123]
Categories
  • Alimentary Tract and Metabolism
  • Amides
  • BCRP/ABCG2 Substrates
  • Blood Glucose Lowering Agents
  • BSEP/ABCB11 Inhibitors
ATC-CodeA10BB01
CAS number10238-21-8

Drug Targets

NameTarget SequencePharmacological ActionActions
Sulfonylurea receptor 1, Kir6.2MPLAFCGSENHSAAYRVDQGVLNNGCFVDALNVVPHVFLLFITFPILFIG...unknownblocker
ATP-binding cassette sub-family C member 9MSLSFCGNNISSYNINDGVLQNSCFVDALNLVPHVFLLFITFPILFIGWG...unknownmodulator
Bile salt export pumpMSDSVILRSIKKFGEENDGFESDKSYNNDKKSRLQDEKKGDGVRVGFFQL...unknowninhibitor
ATP-binding cassette sub-family A member 1MACWPQLRLLLWKNLTFRRRQTCQLLLEVAWPLFIFLILISVRLSYPPYE...unknowninhibitor
Mitochondrial ATP-sensitive potassium channelMLSRKGIIPEEYVLTRLAEDPAEPRYRARQRRARFVSKKGNCNVAHKNIR...unknowninhibitor
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL472
PubChem 3488
ChEMBL CHEMBL472
ChEBI CHEBI:5441
CCDC/CSD DUNXAL, DUNXAL01, GEKMUH
COD 7227370